Antihistamines are often the first treatment recommended for chronic hives. However, many people with cold-induced urticaria or symptomatic dermographism still struggle with itching, swelling, and discomfort even while taking daily medication.
Clinical research is working to find new options. The EMBARQ Study is evaluating an investigational injectable medication to learn whether it may help adults whose symptoms remain uncontrolled.
Clinical trials provide structured monitoring, detailed safety oversight, and clear communication with research teams. Participants are informed about potential risks and benefits through an informed consent process before joining.
While investigational treatments are not yet approved, studies like EMBARQ help researchers better understand chronic urticaria and move toward future treatment possibilities.